"Ke kākoʻo nei ka ʻōlelo aʻoaʻo o kēia lā i ka hoʻohana ʻana i ka lāʻau lapaʻau ʻo Johnson & Johnson COVID-19 ma ke ʻano he mea hoʻoikaika no nā poʻe kūpono i ka US me ka nānā ʻole i ke kano i loaʻa mua iā lākou," wahi a Paul Stoffels, MD, Hope Pelekikena o ke Kōmike Hoʻokō a me Luna Nui ʻepekema ma. Johnson & Johnson. "Ua hāʻawi ka lāʻau lapaʻau ʻo Johnson & Johnson i 94 pākēneka o ka pale ʻana i ka US e kūʻē i ka COVID-19 i ka wā i hāʻawi ʻia ma ke ʻano he mea hoʻoikaika ma hope o ke kano hoʻokahi ʻo Johnson & Johnson, a ma muli o kāna ʻano hana kūʻokoʻa, hāʻawi i ka pale mau loa. Ke hilinaʻi nei mākou i ka pōmaikaʻi e hāʻawi ʻia i nā miliona a puni ka honua. "
Ua ʻōlelo ʻia ka lāʻau lapaʻau ʻo Johnson & Johnson COVID-19 ma ke ʻano he mea hoʻoikaika no nā pākeke he 18 a ʻoi aku ka nui o ka loaʻa ʻana o ka lāʻau lapaʻau hoʻokahi ʻo Johnson & Johnson ma kahi o ʻelua mahina ma mua. Ua ʻōlelo ʻia kahi maʻi booster o ka maʻi kano ʻo Johnson & Johnson COVID-19 no nā pākeke kūpono ma ka liʻiliʻi o ʻeono mahina ma hope o ka lua o ka maʻi maʻi mRNA i ʻae ʻia.
Ua hoʻouna ʻia ka ʻōlelo aʻoaʻo ACIP i ka Luna Hoʻokele o ka CDC a me ka US Department of Health and Human Services (HHS) no ka loiloi a me ka hoʻokomo ʻana.
Ua loaʻa i ka lāʻau lapaʻau COVID-19 ka nui o ka hui i ka FDA Emergency Use Authorization no nā pākeke he 18 a keu aku ma Pepeluali 27, 2021. no nā mākua he 20 a ʻoi aku ma mua o ʻelua mahina ma hope o ka loaʻa ʻana o ka lāʻau lapaʻau mua me ka lāʻau lapaʻau hoʻokahi a ka Hui.
Hoʻohana Kūpono
Ua ʻae ʻia ka Janssen COVID-19 Vaccine no ka hoʻohana ʻana ma lalo o kahi Emergency Use Authorization (EUA) no ka pale ʻana i ka maʻi Coronavirus 2019 (COVID-19) i hoʻokumu ʻia e ka maʻi ʻeha hanu maʻi coronavirus 2 (SARS-CoV-2) e hāʻawi:
• ʻO ke ʻano o ka lāʻau lapaʻau mua no ka Janssen COVID-19 Vaccine he hoʻokahi-dose (0.5 mL) i hāʻawi ʻia i nā poʻe 18 makahiki a ʻoi aku.
• Hiki ke hāʻawi ʻia i ka lāʻau lapaʻau Janssen COVID-19 hoʻokahi (0.5 mL) ma ka liʻiliʻi o 2 mau mahina ma hope o ka hoʻopaʻa ʻana mua i nā poʻe 18 makahiki a ʻoi aku.
• Hiki ke hoʻohana ʻia kahi maʻi hoʻoikaika hoʻokahi o Janssen COVID-19 Vaccine (0.5 mL) ma ke ʻano he heterologous booster dose ma hope o ka pau ʻana o ka lāʻau lapaʻau mua me kekahi kano COVID-19 i ʻae ʻia. ʻO ka heluna kanaka kūpono a me ka wā hoʻopaʻa ʻana no ka nui heterologous booster ua like ia me ka poʻe i ʻae ʻia no ka hoʻoikaika ʻana o ka lāʻau lapaʻau i hoʻohana ʻia no ka lāʻau lapaʻau mua.
IMFORMATION SAFETY IMPORTANT
He aha kāu e haʻi aku ai i kāu mea hāʻawi maʻi ma mua o ka loaʻa ʻana o ka maʻi JANSSEN COVID-19?
E haʻi i ka mea nāna e hāʻawi i ka lāʻau lapaʻau e pili ana i kāu mau maʻi olakino a pau, e like me ʻoe:
• loaʻa kekahi ʻalergi
• loaa ke kuni
• loaʻa i ka maʻi koko a i ʻole aia ma kahi ʻāpana koko
• ua hoʻopilikia ʻia ka maʻi immunocompromised a i ʻole ma kahi lāʻau lapaʻau e pili ana i kou ʻōnaehana pale
• hāpai a hoʻolālā paha e hāpai
• e hānai ana
• ua loaʻa i kekahi kano COVID-19 hou
• ua maule i ka hui pu ana me ka injection
ʻO wai ka mea pono ʻole e loaʻa i ka JANSSEN COVID-19 VACCINE?
ʻAʻole pono ʻoe e kiʻi i ka Vaccine Janssen COVID-19 inā ʻoe:
• loa'a ka ma'i ma'i ko'iko'i ma hope o ka loa'a mua 'ana o kēia kano
• loa'a ka ma'i ma'i ko'iko'i i kekahi mea o keia kano.
Pehea ka hāʻawi ʻia ʻana o ka maʻi JANSSEN COVID-19?
Hāʻawi ʻia ka Vaccine Janssen COVID-19 iā ʻoe ma ke ʻano he injection i loko o ka mākala.
ʻO ka lāʻau lapaʻau mua: Hāʻawi ʻia ka Janssen COVID-19 Vaccine ma ke ʻano hoʻokahi.
Hana Booster:
• Hiki ke hāʻawi ʻia i ʻelua mahina ma hope o ka hoʻopaʻa ʻana mua me ka Janssen COVID-19 Vaccine.
• Hiki ke hāʻawi ʻia kahi maʻi hoʻoikaika hoʻokahi o ka Vaccine COVID-19 Janssen i nā poʻe kūpono i hoʻopau i ka lāʻau lapaʻau mua me kahi lāʻau lapaʻau ʻē aʻe i ʻae ʻia a i ʻae ʻia. E ʻoluʻolu e kamaʻilio me kāu mea mālama ola e pili ana i ke kūpono a me ka manawa o ka hoʻonui ʻana.
He aha nā pilikia o ka JANSSEN COVID-19 VACCINE?
Nā hopena ʻaoʻao i hōʻike ʻia me ka Vaccine Janssen COVID-19 pū me:
• Nā hopena o ka wahi i hoʻopaʻa ʻia: ʻeha, ʻulaʻula o ka ʻili, a me ka pehu.
• Nā hopena maʻamau: ke poʻo, ka luhi loa, ka ʻeha ʻiʻo, ka nausea, ke kuni.
• ʻO nā pūnana lymph pehu.
• Ke koko koko.
• ʻO ka manaʻo ʻokoʻa i ka ʻili (e like me ke kani ʻana a i ʻole ka manaʻo kolo) (paresthesia), hoʻemi ʻia ka manaʻo a i ʻole ka naʻau, ʻoi loa i ka ʻili (hypoesthesia).
• Ke kani mau ana i ka pepeiao (tinnitus).
• ʻO ka maʻi maʻi, ka luaʻi.
Nā Hōʻalo Alergic koʻikoʻi
Aia kahi manawa mamao loa e hiki i ka Janssen COVID-19 Vaccine ke hana i kahi hopena maʻi maʻi nui. E hana maʻamau kahi hopena maʻi maʻi i loko o kekahi mau minuke i hoʻokahi hola ma hope o ka loaʻa ʻana o kahi lāʻau o ka Janssen COVID-19 Vaccine. No kēia kumu, e noi paha kāu mea hāʻawi iā ʻoe e noho ma kahi i loaʻa ai iā ʻoe kāu lāʻau lapaʻau no ka nānā ʻana ma hope o ka lāʻau lapaʻau ʻana. Hiki i nā hōʻailona o ka hopena maʻi ʻino ke komo pū me:
• pilikia ka hanu
• Ka pehu o kou maka a me kou puu
• Ka puʻuwai wikiwiki
• He ma'i 'ino ma kou kino a pau
• ʻO ka noʻonoʻo a me ka nāwaliwali
ʻO nā kīʻaha koko me nā pae haʻahaʻa o nā platelet
ʻO nā kīʻaha koko e pili ana i nā kīʻaha koko i ka lolo, akemāmā, ʻōpū, a me nā wāwae me nā haʻahaʻa haʻahaʻa o nā platelet (nā huna koko e kōkua i kou kino e hoʻōki i ke kahe ʻana o ke kahe), ua loaʻa i kekahi poʻe i loaʻa i ka Vaccine Janssen COVID-19. I ka poʻe i hoʻomohala i kēia mau kahe o ke koko a me nā pae haʻahaʻa o nā platelet, hoʻomaka nā ʻōuli ma kahi o hoʻokahi a ʻelua mau pule paha ma hope o ka lāʻau ʻana. ʻO ka hōʻike ʻana i kēia kōhe koko a me nā pae haʻahaʻa o nā platelet i kiʻekiʻe loa i nā wahine 18 a 49 mau makahiki. ʻO ka manawa kūpono o kēia hana he mamao. Pono ʻoe e ʻimi koke i ka lāʻau inā loaʻa iā ʻoe kekahi o nā ʻōuli ma hope o ka loaʻa ʻana iā Janssen COVID-19 Vaccine:
• Pokole o ka hanu,
• ʻeha o ka umauma,
• pehu wāwae,
• ʻeha mau o ka ʻōpū,
• ʻO ka maʻi poʻo koʻikoʻi a i ʻole ka hoʻomau ʻana a i ʻole ka ʻike pohihihi.
• ʻO ka ʻeha maʻalahi a i ʻole nā kiko koko liʻiliʻi ma lalo o ka ʻili ma waho o ke kahua o ka injection.
ʻAʻole paha kēia nā hopena āpau o ka Vaccine Janssen COVID-19. Hiki paha nā hopena koʻikoʻi a me nā mea i manaʻo ʻole ʻia. Ke aʻo ʻia nei ʻo ka Janssen COVID-19 Vaccine i nā hoʻokolohua hoʻokolohua.
ʻO Guillain Barré Syndrome
ʻO Guillain Barré Syndrome (kahi maʻi neurological kahi e hōʻino ai ke kino pale o ke kino i nā pūnana nerve, e hoʻoulu ana i ka nāwaliwali o nā mākala a i kekahi manawa ka maʻi lōlō) i kekahi poʻe i loaʻa i ka Vaccine Janssen COVID-19. I ka hapa nui o kēia poʻe, ua hoʻomaka nā ʻōuli ma loko o 42 mau lā ma hope o ka loaʻa ʻana o ka Vaccine Janssen COVID-19. He haʻahaʻa loa ka manawa o kēia hana. Pono ʻoe e ʻimi koke i ka lāʻau inā hana ʻoe i kekahi o nā ʻōuli ma hope o ka loaʻa ʻana o ka Vaccine ʻo Janssen COVID-19:
• ʻO ka nawaliwali a i ʻole ke kani ʻana, ʻo ia hoʻi ma nā wāwae a i ʻole nā lima, ke ulu aʻe nei a laha i nā wahi ʻē aʻe o ke kino.
• Paʻakikī i ka hele wāwae.
• Paʻakikī me ka neʻe ʻana o ka maka, e like me ka ʻōlelo ʻana, ka nau ʻana, a i ʻole ka ʻai ʻana.
• ʻIke pālua a hiki ʻole ke neʻe i nā maka.
• Paʻakikī me ka hoʻomalu ʻana i ka ʻōpū a i ʻole ka hana ʻōpū.
He aha kaʻu e hana ai e pili ana i nā hopena ʻaoʻao?
Inā loaʻa iā ʻoe kahi maʻi maʻi koʻikoʻi, e kelepona iā 9-1-1, a i ʻole e hele i ka haukapila kokoke loa.
E kelepona i ka mea lapaʻau a i ʻole kāu mea mālama ola inā loaʻa iā ʻoe nā hopena ʻaoʻao e hoʻopilikia iā ʻoe a ʻaʻole hele.
E hōʻike i nā hopena ʻaoʻao o ka lāʻau lapaʻau iā FDA/CDC Vaccine Adverse Event Reporting System (VAERS). He 1-800-822-7967 ka helu kaʻa ʻole VAERS a i ʻole hōʻike pūnaewele ma vaers.hhs.gov. E ʻoluʻolu e hoʻokomo iā "Janssen COVID-19 Vaccine EUA" ma ka laina mua o ka pahu #18 o ka palapala hōʻike. Eia hou, hiki iā ʻoe ke hōʻike i nā hopena ʻaoʻao iā Janssen Biotech Inc. ma 1-800-565-4008.
Hiki iaʻu ke loaʻa i ka JANSSEN COVID-19 VACCINE I KA MANAWA HOʻI ME NA MAʻI ʻEA?
ʻAʻole i waiho ʻia ka ʻikepili i ka FDA no ka hoʻokele ʻana i ka Janssen COVID-19 Vaccine i ka manawa like me nā maʻi ʻē aʻe. Inā ʻoe e noʻonoʻo ana e loaʻa i ka Janssen COVID-19 Vaccine me nā lāʻau lapaʻau ʻē aʻe, e kūkākūkā i kāu mau koho me kāu mea mālama ola.
He aha e lawe ʻia mai kēia ʻatikala:
- The eligible population(s) and dosing interval for the heterologous booster dose are the same as those authorized for a booster dose of the vaccine used for primary vaccination.
- A single booster dose of the Janssen COVID-19 Vaccine may be administered to eligible individuals who have completed primary vaccination with a different authorized or approved COVID-19 vaccine.
- Hiki ke lawelawe ʻia kahi maʻi hoʻoikaika hoʻokahi o ka Janssen COVID-19 Vaccine ma kahi o ʻelua mahina ma hope o ka hoʻopaʻa ʻana mua me ka Janssen COVID-19 Vaccine.